d-alpha tocopherol has been researched along with tacrolimus in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baldassare, M; Buccione, R; Luini, A; Pompeo, A | 1 |
| Fernando, ON; Fernando, RL; Moorhead, JF; Powis, SH; Psimenou, E; Sweny, P; Turakhia, G; Varghese, Z | 1 |
| Passerini, P; Ponticelli, C | 1 |
| Elinav, H; Granot, E; Kohen, R | 1 |
| Conte, MA; Kamel, S; Louandre, C; Massy, Z; Mazière, C; Mazière, JC; Morlière, P | 1 |
| Aaronson, KD; Gorman, LE; Koelling, TM; Lake, KD; Pagani, FD | 1 |
| Antonicelli, F; Conte, MA; Gomilla, C; Hornebeck, W; Louandre, C; Mazière, C; Mazière, JC; Morlière, P; Santus, R | 1 |
| Akbasli, AC; Erbay, B; Keven, K; Nebioglu, S | 1 |
| Haddad, E; Hatami, A; Marcoux, D; McCuaig, CC; Piram, M; Powell, J; Saint-Cyr, C | 1 |
| Ding, W; Du, Y; Han, X; He, Z; Kou, L; Li, L; Lian, H; Liu, Y; Luo, C; Qiu, S; Sun, J; Wang, M; Wang, Y; Xiang, R; Zhai, Y; Zhang, D | 1 |
| Long, Y; Pan, J; Pan, W; Qin, M; Ruan, W; Wan, T; Wang, Y; Wu, C; Xu, Y; Yu, K | 1 |
| Berntsen, HF; Bogen, IL; Fonnum, F; Moldes-Anaya, A; Walaas, SI; Wigestrand, MB | 1 |
2 review(s) available for d-alpha tocopherol and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of focal segmental glomerulosclerosis.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Blood Component Removal; Cyclosporine; Drug Resistance; Glomerulosclerosis, Focal Segmental; Humans; Immunosorbent Techniques; Pefloxacin; Purines; Tacrolimus; Vitamin E | 2001 |
1 trial(s) available for d-alpha tocopherol and tacrolimus
| Article | Year |
|---|---|
Changes in oxidative stress in renal graft patients receiving calcineurin inhibitors: cyclosporine versus tacrolimus.
Topics: Adult; Antioxidants; Ascorbic Acid; Calcineurin Inhibitors; Cyclosporine; Enzyme Inhibitors; Female; Follow-Up Studies; Glutathione; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Male; Malondialdehyde; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Tacrolimus; Vitamin E; Young Adult | 2012 |
11 other study(ies) available for d-alpha tocopherol and tacrolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells.
Topics: Animals; Arachidonic Acid; Cell Division; Cell Size; Cell Survival; Cyclosporine; Dexamethasone; Digitonin; Dose-Response Relationship, Drug; Enzyme Activation; Immunosuppressive Agents; Interleukin-1; Melitten; Mice; Phospholipases A; Phospholipases A2; Pituitary Neoplasms; Tacrolimus; Terpenes; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vitamin E | 1999 |
Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients.
Topics: Adult; Ascorbic Acid; Calcineurin Inhibitors; Cholesterol; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Tacrolimus; Time Factors; Triglycerides; Urea; Vitamin E | 1999 |
Markers of oxidative stress in cyclosporine-treated and tacrolimus-treated children after liver transplantation.
Topics: Adolescent; Antioxidants; Biomarkers; Blood; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lipoproteins; Liver Transplantation; Male; Molecular Weight; Oxidation-Reduction; Oxidative Stress; Postoperative Care; Postoperative Period; Tacrolimus; Vitamin A; Vitamin E | 2002 |
Oxidized low-density lipoprotein elicits an intracellular calcium rise and increases the binding activity of the transcription factor NFAT.
Topics: Antioxidants; Calcineurin Inhibitors; Calcium; Calcium Signaling; Cell Line; Chelating Agents; Cyclosporine; DNA; Egtazic Acid; Endothelial Cells; Fibroblasts; Humans; Lipoproteins, LDL; Macrophages; NFATC Transcription Factors; Protein Binding; Reactive Oxygen Species; Tacrolimus; Vitamin E | 2005 |
Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients.
Topics: Adult; Age Factors; Aged; Antioxidants; Ascorbic Acid; Biomarkers; Calcineurin; Calcineurin Inhibitors; Cohort Studies; Cyclosporine; Drug Interactions; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Male; Middle Aged; Postoperative Care; Probability; Retrospective Studies; Risk Assessment; Sex Factors; Tacrolimus; Transplantation Immunology; Treatment Outcome; Vitamin E | 2005 |
Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium-calcineurin pathway.
Topics: Antioxidants; Calcineurin; Calcineurin Inhibitors; Calcium; Cell Survival; Cells, Cultured; Cyclosporine; DNA; Dose-Response Relationship, Radiation; Egtazic Acid; Fibroblasts; Humans; NFATC Transcription Factors; Protein Binding; Signal Transduction; Tacrolimus; Ultraviolet Rays; Vitamin E | 2005 |
Short- and long-term outcome of linear morphoea in children.
Topics: Adolescent; Adrenal Cortex Hormones; Age of Onset; Aminoquinolines; Calcitriol; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Imiquimod; Male; Methotrexate; Ointments; Phototherapy; Retrospective Studies; Scleroderma, Localized; Tacrolimus; Treatment Outcome; Vitamin A; Vitamin E | 2013 |
Enteric polymer based on pH-responsive aliphatic polycarbonate functionalized with vitamin E to facilitate oral delivery of tacrolimus.
Topics: Administration, Oral; Animals; Drug Carriers; Hydrogen-Ion Concentration; Intestinal Absorption; Micelles; Polycarboxylate Cement; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tacrolimus; Tissue Distribution; Vitamin E | 2015 |
Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy.
Topics: Animals; Cell Line; Drug Carriers; Humans; Male; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Psoriasis; Rats, Sprague-Dawley; Skin Absorption; Tacrolimus; Vitamin E | 2017 |
The fungal neurotoxin penitrem A induces the production of reactive oxygen species in human neutrophils at submicromolar concentrations.
Topics: Anthracenes; Antioxidants; Calcineurin; Cell Line; Cyclosporine; Granulocytes; Humans; Imidazoles; Inhibitory Concentration 50; JNK Mitogen-Activated Protein Kinases; Mycotoxins; Neurotoxins; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Tacrolimus; Vitamin E | 2017 |